<DOC>
	<DOCNO>NCT00776633</DOCNO>
	<brief_summary>The investigator hypothesize reduce duration clopidogrel therapy 6 month 6 week DES implantation associate improved clinical outcome patient ASA oral anticoagulant .</brief_summary>
	<brief_title>Triple Therapy Patients Oral Anticoagulation After Drug Eluting Stent Implantation</brief_title>
	<detailed_description>The introduction drug-eluting stent ( DES ) associate widen indication percutaneous coronary intervention ( PCI ) also longer antithrombotic therapy duration . Dual antiplatelet therapy ASA thienopyridine efficient prevent adverse event coronary stenting inferior oral anticoagulation ( OAC ) reduce risk stroke patient atrial fibrillation . OAC also superior antiplatelet therapy patient mechanical heart valve therapy choice treatment deep vein thrombosis pulmonary embolism . OAC also administer leave ventricular thrombus low ejection fraction . There increase number patient undergoing coronary stenting need life-long anticoagulation therapy would therefore require triple therapy consist aspirin , clopidogrel oral anticoagulation . As oral anticoagulation antithrombotic therapy impair primary secondary hemostasis concern add warfarin dual antiplatelet therapy might cause increased bleeding rate . Several study retrospectively assess efficacy safety patient receive triple therapy various result : major bleed rate vary 3,1 % -14,9 % total bleeding rate 27,5 % . Prospective randomize data topic available . Therefore aim study compare 6 week versus 6 month triple therapy DES implantation .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Key 1 . Patients indication oral anticoagulation DES implantation . 2 . Informed , write consent patient her/his legallyauthorized representative participation study . Key 1 . Age â‰¤18 year 2 . Previous stent thrombosis 3 . DES leave main</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>aspirin</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>oral anticoagulation</keyword>
	<keyword>warfarin</keyword>
	<keyword>drug elute stent</keyword>
	<keyword>phenprocoumon</keyword>
</DOC>